Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
9,783,925
-
Total 13F shares
-
8,582,106
-
Share change
-
+6,105,290
-
Total reported value
-
$11,395,569
-
Price per share
-
$1.38
-
Number of holders
-
29
-
Value change
-
+$7,977,439
-
Number of buys
-
15
-
Number of sells
-
6
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q4 2023
As of 31 Dec 2023,
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,582,106 shares.
The largest 10 holders included
AIGH Capital Management LLC, Ensign Peak Advisors, Inc, Alyeska Investment Group, L.P., 683 Capital Management, LLC, VANGUARD GROUP INC, Voss Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Stonegate Investment Group, LLC, Rock Creek Group, LP, and Sigma Planning Corp.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.